Indication
Malignant Pheochromocytoma
2 clinical trials
2 products
Clinical trial
A Study on the Efficacy and Safety of Penpulimab in the Treatment of Metastatic Pheochromocytoma/Paraganglioma Patients Who Fail to Other Systemic TreatmentStatus: Recruiting, Estimated PCD: 2025-03-01
Product
PenpulimabClinical trial
The Efficacy and Safety of Temozolomide in Patients With Metastatic Pheochromocytoma or ParagangliomaStatus: Completed, Estimated PCD: 2022-10-01
Product
TMZ